Home › Funds › Ilex Capital Partners (UK) LLP › ELV

Ilex Capital Partners (UK) LLP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Ilex Capital Partners (UK) LLP reported holding 113,556 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$43.9M, representing 0.90% of its reported portfolio and ranking #36 among its reported holdings. Ilex Capital Partners (UK) LLP has disclosed ELV holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)113.56K sh
Reported value held$43.92M
Portfolio Weight0.90%
First reportedQ1 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ilex Capital Partners (UK) LLP's ELV position evolved

Ilex Capital Partners (UK) LLP first disclosed a stake in ELV in Q1 2025 at 7,607 shares (US$3.3M). The position peaked in Q2 2026 at 113,556 shares, worth US$43.9M. Across 4 filings, Ilex Capital Partners (UK) LLP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 113,556 shares valued at US$43.9M. Notable position changes include a 55% trim in Q2 2025 (shares fell 16% over the following quarter), a 61% trim in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 7.61K $3.31M New
Q2 2025 3.41K $1.33M Reduce
Q3 2025 1.33K $431.37K Reduce
Q2 2026 113.56K $43.92M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Ilex Capital Partners (UK) LLP held ELV?

Ilex Capital Partners (UK) LLP has disclosed ELV holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

What is Ilex Capital Partners (UK) LLP's current position in ELV?

As of Q2 2026, Ilex Capital Partners (UK) LLP holds 113.56K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $43.92M, representing 0.90% of its reported portfolio and ranking #36.

Has Ilex Capital Partners (UK) LLP been buying or selling ELV?

In the latest 13F filing (Q2 2026), Ilex Capital Partners (UK) LLP newly opened its position in ELV. The position peaked in Q2 2026 at 113.56K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.